Walter Hanel

6PUBLICATIONS
58CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 06, 2026
Enhancing tyrosine kinase inhibitor sensitivity by restoring IKAROS activity on GLUT1 expression and glycolysis in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Linyao Zhang, Qi Han, Huimin Xiang

|Feb 04, 2026
Clinical characteristics associated with terminal methotrexate clearance in patients with non-Hodgkin lymphomas receiving high-dose methotrexate.

Zachary J Arnold, Jordan Lundberg, Tracy Wiczer

|Aug 26, 2025
The Novel Immunocompetent Eµ-SOX11CCND1 Mouse Model Phenotypically and Molecularly Resembles Human Mantle Cell Lymphoma.

Hedieh Jafari, Fiona Brown-Burke, Betsy Pray

|Dec 14, 2023
Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas.

Zachary Braunstein, Allyson Waller, Emily Dotson

|Aug 19, 2023
Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma.

Anuvrat Sircar, Satishkumar Singh, Zijun Y Xu-Monette

|Mar 11, 2023
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma.

Walter Hanel, Polina Shindiapina, David A Bond

Pageof 1

Frequent Collaborators

3 joint publications

Narendranath Epperla

3 joint publications

Lapo Alinari

3 joint publications

John Reneau

2 joint publications

Rosa Lapalombella